The global whole exome sequencing market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for personalized medicine and the need for accurate diagnosis of rare diseases.
The global whole exome sequencing market is segmented on the basis of type, application, and region. On the basis of type, it is categorized into Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap and MYcroarray MYbaits. On the basis of application it includes correlation research in normal human population as well as Mendelian disease and rare syndrome gene discovery; research in complex diseases; mouse exome sequencing; and others (e.g., cancer). On the basis of region it includes North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- The cost of whole exome sequencing is decreasing, which will make it more accessible to the general public.
- Whole exome sequencing can be used to diagnose genetic diseases and cancers, which will increase demand for this technology.
- Whole exome sequencing can be used in research to identify genes that are associated with certain diseases or traits, which will increase demand for this technology in the future as well as now because it is a relatively new field of study and there are many unknowns about how genes affect our health and behavior.
- The number of people who have access to whole exome sequencing is increasing due to its use in research studies and clinical trials, which will also increase demand for this technology over time as more people become aware of its benefits and uses.
- There are many potential applications for whole exome sequencing that have not yet been discovered or developed, so there may be other factors that contribute to market growth but we do not know about them yet.
Industry Growth Insights published a new data on “Whole Exome Sequencing Market”. The research report is titled “Whole Exome Sequencing Market research by Types (Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin), By Applications (Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing), By Players/Companies Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, Whole Exome Sequencin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Whole Exome Sequencing Market Research Report
By Type
Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin
By Application
Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing
By Companies
Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, Whole Exome Sequencin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Whole Exome Sequencing Market Report Segments:
The global Whole Exome Sequencing market is segmented on the basis of:
Types
Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits, Whole Exome Sequencin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Thermo Fisher
- Roche
- Angilent
- Eurofins
- Sengenics
- Ambry
- Macrogen
- BGI
- Novo Gene
- Whole Exome Sequencin
Highlights of The Whole Exome Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Agilent HaloPlex
- Agilent SureSelect
- Agilent SureSelect QXT
- Illumina TruSeq Exome
- Roche Nimblegen SeqCap
- MYcroarray MYbaits
- Whole Exome Sequencin
- By Application:
- Correlation Research of Normal Human
- Mendelian Disease and Rare Syndrome Gene Discovery
- The Research of Complex Diseases
- Mouse Exome Sequencing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Whole Exome Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Whole exome sequencing is a type of genetic testing that examines the complete set of genes in a person's genome. This includes all the DNA found on chromosomes 1, 2, 3, and 4.
Some of the major companies in the whole exome sequencing market are Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, Whole Exome Sequencin.
The whole exome sequencing market is expected to grow at a compound annual growth rate of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Whole Exome Sequencing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Whole Exome Sequencing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Whole Exome Sequencing Market - Supply Chain
4.5. Global Whole Exome Sequencing Market Forecast
4.5.1. Whole Exome Sequencing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Whole Exome Sequencing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Whole Exome Sequencing Market Absolute $ Opportunity
5. Global Whole Exome Sequencing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Whole Exome Sequencing Market Size and Volume Forecast by Type
5.3.1. Agilent HaloPlex
5.3.2. Agilent SureSelect
5.3.3. Agilent SureSelect QXT
5.3.4. Illumina TruSeq Exome
5.3.5. Roche Nimblegen SeqCap
5.3.6. MYcroarray MYbaits
5.3.7. Whole Exome Sequencin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Whole Exome Sequencing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Whole Exome Sequencing Market Size and Volume Forecast by Application
6.3.1. Correlation Research of Normal Human
6.3.2. Mendelian Disease and Rare Syndrome Gene Discovery
6.3.3. The Research of Complex Diseases
6.3.4. Mouse Exome Sequencing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Whole Exome Sequencing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Whole Exome Sequencing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Whole Exome Sequencing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Whole Exome Sequencing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Whole Exome Sequencing Demand Share Forecast, 2019-2026
9. North America Whole Exome Sequencing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Whole Exome Sequencing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Whole Exome Sequencing Market Size and Volume Forecast by Application
9.4.1. Correlation Research of Normal Human
9.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
9.4.3. The Research of Complex Diseases
9.4.4. Mouse Exome Sequencing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Whole Exome Sequencing Market Size and Volume Forecast by Type
9.7.1. Agilent HaloPlex
9.7.2. Agilent SureSelect
9.7.3. Agilent SureSelect QXT
9.7.4. Illumina TruSeq Exome
9.7.5. Roche Nimblegen SeqCap
9.7.6. MYcroarray MYbaits
9.7.7. Whole Exome Sequencin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Whole Exome Sequencing Demand Share Forecast, 2019-2026
10. Latin America Whole Exome Sequencing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Application
10.4.1. Correlation Research of Normal Human
10.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
10.4.3. The Research of Complex Diseases
10.4.4. Mouse Exome Sequencing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Whole Exome Sequencing Market Size and Volume Forecast by Type
10.7.1. Agilent HaloPlex
10.7.2. Agilent SureSelect
10.7.3. Agilent SureSelect QXT
10.7.4. Illumina TruSeq Exome
10.7.5. Roche Nimblegen SeqCap
10.7.6. MYcroarray MYbaits
10.7.7. Whole Exome Sequencin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Whole Exome Sequencing Demand Share Forecast, 2019-2026
11. Europe Whole Exome Sequencing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Whole Exome Sequencing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Whole Exome Sequencing Market Size and Volume Forecast by Application
11.4.1. Correlation Research of Normal Human
11.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
11.4.3. The Research of Complex Diseases
11.4.4. Mouse Exome Sequencing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Whole Exome Sequencing Market Size and Volume Forecast by Type
11.7.1. gilent HaloPlex
11.7.2. Agilent SureSelect
11.7.3. Agilent SureSelect QXT
11.7.4. Illumina TruSeq Exome
11.7.5. Roche Nimblegen SeqCap
11.7.6. MYcroarray MYbaits
11.7.7. Whole Exome Sequencin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Whole Exome Sequencing Demand Share, 2019-2026
12. Asia Pacific Whole Exome Sequencing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Application
12.4.1. Correlation Research of Normal Human
12.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
12.4.3. The Research of Complex Diseases
12.4.4. Mouse Exome Sequencing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Whole Exome Sequencing Market Size and Volume Forecast by Type
12.7.1. Agilent HaloPlex
12.7.2. Agilent SureSelect
12.7.3. Agilent SureSelect QXT
12.7.4. Illumina TruSeq Exome
12.7.5. Roche Nimblegen SeqCap
12.7.6. MYcroarray MYbaits
12.7.7. Whole Exome Sequencin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Whole Exome Sequencing Demand Share, 2019-2026
13. Middle East & Africa Whole Exome Sequencing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Application
13.4.1. Correlation Research of Normal Human
13.4.2. Mendelian Disease and Rare Syndrome Gene Discovery
13.4.3. The Research of Complex Diseases
13.4.4. Mouse Exome Sequencing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Whole Exome Sequencing Market Size and Volume Forecast by Type
13.7.1. Agilent HaloPlex
13.7.2. Agilent SureSelect
13.7.3. Agilent SureSelect QXT
13.7.4. Illumina TruSeq Exome
13.7.5. Roche Nimblegen SeqCap
13.7.6. MYcroarray MYbaits
13.7.7. Whole Exome Sequencin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Whole Exome Sequencing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Whole Exome Sequencing Market: Market Share Analysis
14.2. Whole Exome Sequencing Distributors and Customers
14.3. Whole Exome Sequencing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumina
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Angilent
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eurofins
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sengenics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ambry
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Macrogen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BGI
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novo Gene
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Whole Exome Sequencin
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.
